• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

China SXT Pharmaceuticals, Inc. - Common Stock (NQ:SXTC)

0.0950 -0.0111 (-10.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about China SXT Pharmaceuticals, Inc. - Common Stock

News headline image
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 15, 2026
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 09, 2026
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Market Signals Flash Bullish for RDZN, NVVE, JTAI, SXTC, UAVS – Momentum Pointing Higher
January 09, 2026
Via AB Newswire
Topics Artificial Intelligence Fraud
News headline image
Roadzen (NASDAQ: RDZN) Strengthens Platform with Strategic VehicleCare Acquisition – Market Signals Point to New Highs Alongside NVVE, JTAI, SXTC, UAVS
January 08, 2026
Via AB Newswire
Topics Artificial Intelligence Fraud
News headline image
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
January 08, 2026
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
March 17, 2025
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
February 21, 2025
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
October 07, 2024
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
October 26, 2023
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
May 10, 2023
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
November 07, 2022
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).
January 20, 2022
NEW YORK, NY / ACCESSWIRE / January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China... 
From Aegis Capital Corp.
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap